Member Info for MaverickD

Well let’s wait for more clarity, but it looks like we have some positive movement on Tim’s interview……..should see any of the doomsters steer clear. 700k buy gone in…..well its hard to argue with the buys

It’s up…..gapping

I’m positive……but lets just read it again

It’s going to 40p…….@Masterblast your comment from 2023, when you must have been invested. lol now it’s about peanuts.

@Nolupus yes the sp is getting g a decent bid with the selling and has been above 3p today……no news is just that - no news. We wait to hear what is happening when we read an official RNS

@Nolupus - thought it would be good to post the history element and correct my comment, as I was here stating be factual - I should have used the word “committed’ although they did buy shares at 11p and 5p I believe. Happy to be correct if this is an error

AIM minnow ImmuPharma demonstrated today (29/11/2019) just why investors continue to back small companies on London’s junior market. In just a few hours, shares in the £12 million drug firm had quadrupled in value, netting lucky – and brave – investors a handsome profit.

Immupharma shares closed last night at a fraction over 7p, but investors got excited when the company announced a licence and development agreement with Avion Pharmaceuticals to commercialise Lupuzor in the enormous US market. The drug is used to treat Lupus, a potentially life-threatening auto-immune disease, but might also work for other auto-immune diseases.

Minutes before 11am, Immupharma shares were changing hands for 28p, valuing the business at over £40 million. It’s a far cry from April 2018 when the price crashed 85% from about 180p after the company admitted that trials of Lupuzor were unable to demonstrate the drug was any better than a placebo. That bombshell came just months after the company had raised £10 million from a share placing at 144p.

As part of today’s deal, Avion will also be able to use trademarks to development, manufacture and commercialisation of products under the licence deal.

Avion will also bankroll a 52-week international Phase III trial in lupus patients in the US, Europe and elsewhere in 2020 up to $25 million. Immupharma will also get milestone payments of up to $70 million - $5 million on regulatory approval and $65 million on hitting sales targets. Further approvals other than Lupus will also trigger a $5 million windfall.

Avion has also promised Immupharma tiered double-digit royalties up to 17%, according to pre-specified annual US sales targets.

Avion chief executive says: “After in-depth due-diligence around Lupuzor, its mechanism of action and learnings within the initial Phase III results, we believe that Lupuzor has a unique position within lupus that sets it apart from competition.

“With approximately 1.5 million patients in the US suffering from lupus, there is a significant unmet need for a safe and effective drug for this debilitating disease that we believe Lupuzor can meet.”

This is great news for Immupharma, and that’s reflected in this stratospheric surge in the share price. Bulls will remind us that, even after quadrupling in value, the shares trade at levels significantly below the peak achieved during the previous era of investor excitement between September 2017 and April 2018.

The key here is that we wait to hear the actual news, not state untruths. I just get back to our current market cap of what 12m and the potential upside. We have to understand that Avion have been at our side for 6 years and invested well in excess of £30m. We also “lost’ 2/3 years because of Covid. I don’t think some grasp what that did for the pharma sector - nobody cared about Lupus or Autoimmune diseases…….the world wanted to get back to normality and that was the focus. During this time the SP slid from 12p or so. The current price of circa 3p in my eyes represents good value, when you were here when the initial Stage 3 trial in 2017/18 the SP was circa £2. Yes we has seen dilution, but with so much potential I am happy with my investment and the potential rewards far outweigh the associated risks

Offer price has gone up, can’t confirm trades as ADVFN is down

“This will hit 40p easy”

I’m with MB of 2023……..

Well a number of the earlier trades are buys, but the MMs seem to be eeking out any sells………

Facts are there are more sells than buys now and the offer price is sub 3p as I type.

Well Masterblast said 40p…….he must know lol

Masterblast

I’m killing myself laughing - nobody can put a price on anything the market will value it.

My previous statement had a quote : “This will hit 40p easy”

This is a quote you made in a post in reference to IMM on the 16th June 2023 @15:38 when the share price was 3.2p. I just thought it would be good to quote it back to you and remind you that you were clearly in the boom boom cap previously. Now the only thing I can think has changed is that you have sold, but normally people walk away……..oh unless you want to buy some…….or you like Peterpharma want to help the rest of us with our investment decisions. Hats off to you I am really grateful, we need more selfless people like you in this world.

“This will hit 40p easy”

Waiting for Masterblast to correct me

450k in sells at 3.175 and the bid is holding strong at 3.1 and offer is still 3.4 - that’s actually where we stand. SP is in the blue or green depending on how you call it

Well whatever has been said this morning it has had a positive impact on the sp…….truth is anyone thinking what’s said on here influences the sp is deluded. All about supply and demand…….more demand right now.

Yes posting under an unknown subject line to all of us is misleading

The buys are in at 3.34p right now - offer has moved up to 3.4p

Actually, could I ask any holders that are worried to sell now please as per Peter and Masterblast have been advising. It would definitely provide some needed liquidity, because it’s annoying these wide spreads.

Let’s stick to the facts as of right now - Since 11:29am we are seeing buys filling up…….agreed? Offer price is 3.3 as I type and MMs selling at 3.29. Buys stand at 1.5m and sells 790K, so Buys are 2 to 1.

Lol Masterblast you’ve been registered since 2021 - I’ve been here since 2008………I think its fair to say I’ve got it right more times than I’ve got it wrong, otherwise I’d have lost my shirt a long time ago

Peter we get it you don’t want investors to lose money out of the kindness of your heart. We appreciate it. With regards an to the funding, like I said was a means to an end during a testing time during Covid. There have been delays, agreed, but we look to be coming out of what seemed a tunnel to many and 2025 looks a lot brighter Anyway 425k of buys filled, just wait for the spread to go out again and let’s see what “actual’ news we receive. Lots of speculation from both sides - Bulls and Bears.

Peter there is no RNS release on the 21/9/21. They carried out a Coporate restructure at the end of Sept 21 and re-evaluated their portfolio. Response from the FDA application was the story of 2022 - they had a backlog following Covid. Meeting with the FDA finally came mid 2023. Avion are still in place and I’d imagine we are slowly getting g to where we should have been a long time ago hadn’t the pharma sector along with the rest of the world been ravaged by Cv.19. How on track we are we will find out.